Bucher HC - Search Results

1

Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1.

Chammartin F, Griessbach A, Kusejko K, Audigé A, Epp S, Stoeckle MP, Eichenberger AL, Amstutz A, Schoenenberger CM, Hasse B, Braun DL, Rauch A, Trkola A, Briel M, Bucher HC, Günthard HF, Speich B, Abela IA; Swiss HIV Cohort Study. Chammartin F, et al. Among authors: bucher hc. AIDS. 2024 Feb 1;38(2):217-222. doi: 10.1097/QAD.0000000000003751. Epub 2023 Oct 11. AIDS. 2024. PMID: 37830908

2

Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study.

Furrer H, Opravil M, Rossi M, Bernasconi E, Telenti A, Bucher H, Schiffer V, Boggian K, Rickenbach M, Flepp M, Egger M; Swiss HIV Cohort Study. Furrer H, et al. AIDS. 2001 Mar 9;15(4):501-7. doi: 10.1097/00002030-200103090-00009. AIDS. 2001. PMID: 11242147 Clinical Trial.

3

Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy.

Rossi M, Flepp M, Telenti A, Schiffer V, Egloff N, Bucher H, Vernazza P, Bernasconi E, Weber R, Rickenbach M, Furrer H; Swiss HIV Cohort Study. Rossi M, et al. Swiss Med Wkly. 2001 Aug 11;131(31-32):471-7. doi: 10.4414/smw.2001.09728. Swiss Med Wkly. 2001. PMID: 11641970 Free article.

4

Low incidence of community-acquired pneumonia among human immunodeficiency virus-infected patients after interruption of Pneumocystis carinii pneumonia prophylaxis.

Eigenmann C, Flepp M, Bernasconi E, Schiffer V, Telenti A, Bucher H, Wagels T, Egger M, Furrer H; Swiss HIV Cohort Study. Eigenmann C, et al. Clin Infect Dis. 2003 Apr 1;36(7):917-21. doi: 10.1086/368190. Epub 2003 Mar 18. Clin Infect Dis. 2003. PMID: 12652393 Free article.

5

Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis.

Nordmann AJ, Briel M, Bucher HC. Nordmann AJ, et al. Among authors: bucher hc. Eur Heart J. 2006 Dec;27(23):2784-814. doi: 10.1093/eurheartj/ehl282. Epub 2006 Oct 4. Eur Heart J. 2006. PMID: 17020889 Review.

6

HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy.

Rauch A, Nolan D, Furrer H, McKinnon E, John M, Mallal S, Gaudieri S, Günthard HF, Schmid P, Battegay M, Hirschel B, Telenti A, James I; Swiss HIV Cohort Study. Rauch A, et al. Clin Infect Dis. 2008 Jun 15;46(12):1921-5. doi: 10.1086/588479. Clin Infect Dis. 2008. PMID: 18466093 Free article.

7

Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study.

Vo TT, Ledergerber B, Keiser O, Hirschel B, Furrer H, Battegay M, Cavassini M, Bernasconi E, Vernazza P, Weber R; Swiss HIV Cohort Study. Vo TT, et al. J Infect Dis. 2008 Jun 15;197(12):1685-94. doi: 10.1086/588141. J Infect Dis. 2008. PMID: 18513155 Free article.

8

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.

Monforte Ad, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, Kirk O, Law M, De Wit S, Friis-Møller N, Phillips AN, Sabin CA, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group. Monforte Ad, et al. AIDS. 2008 Oct 18;22(16):2143-53. doi: 10.1097/QAD.0b013e3283112b77. AIDS. 2008. PMID: 18832878 Free PMC article.

9

Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients.

Veit O, Niedrig M, Chapuis-Taillard C, Cavassini M, Mossdorf E, Schmid P, Bae HG, Litzba N, Staub T, Hatz C, Furrer H; Swiss HIV Cohort Study. Veit O, et al. Clin Infect Dis. 2009 Mar 1;48(5):659-66. doi: 10.1086/597006. Clin Infect Dis. 2009. PMID: 19191654 Free article.

10

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.

Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients; Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, Klein MB, Gange S, Riera M, Mussini C, Gutiérrez F, Touloumi G, Carrieri P, Guest JL, Brockmeyer NH, Phillips AN. Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients, et al. Lancet. 2010 Jul 31;376(9738):340-5. doi: 10.1016/S0140-6736(10)60932-4. Epub 2010 Jul 15. Lancet. 2010. PMID: 20638118 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

617 results

Search Page